Addus HomeCare (ADUS) Stock Forecast & Price Target

→ The asset beating inflation by 4x (From Colonial Metals) (Ad)

$119.30

+1.60 (+1.36%)

(As of 06/18/2024 ET)

Addus HomeCare - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 8 Analyst Ratings

Consensus Price Target

$113.43
-4.92% Downside

High Forecast	$130.00
Average Forecast	$113.43
Low Forecast	$83.00

Type	Current Forecast 6/20/23 to 6/19/24	1 Month Ago 5/21/23 to 5/20/24	3 Months Ago 3/22/23 to 3/21/24	1 Year Ago 6/20/22 to 6/20/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)	4 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$113.43	$108.57	$103.83	$112.75
Forecasted Upside	-4.92% Downside	10.94% Upside	14.45% Upside	20.41% Upside

Get Addus HomeCare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.

Ad Weiss Ratings

[Urgent] Protect your money before November

Those who listened to his warnings could have kept their money safe and even made substantial profits during each crisis. In fact, the Wall Street Journal reported that his work was more accurate … and more profitable than that of … Deutsche Bank … Merrill Lynch … JPMorgan Chase … Goldman Sachs … and every other firm reviewed.

Click here to watch now.

ADUS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ADUS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Addus HomeCare Stock vs. The Competition

Type	Addus HomeCare	Medical Companies	S&P 500
Consensus Rating Score	2.75	2.70	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	-4.92% Downside	1,068.20% Upside	11.31% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
6/18/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$119.00 ➝ $128.00	+7.93%
6/7/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$118.00 ➝ $130.00	+12.00%
5/31/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$120.00 ➝ $128.00	+13.27%
5/7/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$115.00 ➝ $118.00	+20.54%
4/23/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Equal Weight ➝ Underweight	$83.00	-11.22%
2/29/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$102.00	+10.62%
Get the Latest News and Ratings for ADUS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter.
2/5/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
8/2/2023	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$100.00 ➝ $105.00	+12.98%
6/28/2022	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$101.00	+21.51%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 06:01 AM ET.

ADUS Forecast - Frequently Asked Questions

What is Addus HomeCare's stock forecast and purchase recommendation?: According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Addus HomeCare is $113.43, with a high forecast of $130.00 and a low forecast of $83.00. The consensus rating for Addus HomeCare stock is Moderate Buy based on the current 1 sell rating and 7 buy ratings for ADUS. Learn more on ADUS's analyst rating history.
Do Wall Street analysts like Addus HomeCare more than its competitors?: Analysts like Addus HomeCare more than other "medical" companies. The consensus rating score for Addus HomeCare is 2.75 while the average consensus rating score for "medical" companies is 2.70. Learn more on how ADUS compares to other companies.
Is Addus HomeCare being downgraded by Wall Street analysts?: Over the previous 90 days, Addus HomeCare's stock had 1 downgrade by analysts.

Does Addus HomeCare's stock price have much upside?: According to analysts, Addus HomeCare's stock has a predicted upside of 9.64% based on their 12-month stock forecasts.
What analysts cover Addus HomeCare?: Addus HomeCare has been rated by research analysts at Bank of America, Barclays, Oppenheimer, Stephens, and TD Cowen in the past 90 days.